ABVC BioPharma, Inc.(NASDAQ : ABVC)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||1.69%||80.84||0.7%||$1589.65m|
|JNJ||Johnson & Johnson||0.01%||163.88||0.7%||$1030.29m|
|BMY||Bristol-Myers Squibb Co.||1.07%||58.21||1.0%||$660.32m|
|LLY||Eli Lilly & Co.||0.46%||243.42||1.1%||$609.86m|
|AVIR||Atea Pharmaceuticals, Inc.||-3.55%||13.33||0.3%||$117.55m|
|NVO||Novo Nordisk A/S||-0.10%||104.55||0.1%||$91.60m|
|EDSA||Edesa Biotech, Inc.||-1.10%||8.13||0.0%||$73.28m|
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of new drugs and medical devices. The company also integrates research achievements from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. It conducts clinical trials of translational medicine for Proof of Concept and out-licenses it to international pharmaceutical companies. Its products include BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia. The company was founded in 1990 and is headquartered in Fremont, CA.